Neogenomics Inc reports results for the quarter ended in June - Earnings Summary

NeoGenomics

08/08/2023 14:33

* Neogenomics Inc  NEO.OQ  reported a quarterly adjusted
loss of 5
cents​​ per share for the quarter ended in June. The mean
expectation of thirteen analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue rose 17.5% to $146.92 million from a year ago;
analysts
expected $137.42 million. 
    * Neogenomics Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Neogenomics Inc shares had fallen by 1.7% this quarter and
gained 71.0% so far this year.
    * The company reported a quarterly loss of $24.33 million.
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $21.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.11          -0.05          Beat
 Mar. 31 2023      -0.15          -0.09          Beat
 Dec. 31 2022      -0.16          -0.06          Beat
 Sep. 30 2022      -0.21          -0.14          Beat